New PET technique may solve brain scan puzzle

NCT ID NCT05762172

Completed Diagnosis Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an early, quick PET scan using F-DOPA can help doctors tell the difference between a brain tumor coming back and damage from radiation therapy. Eight patients who already needed a PET scan for their brain metastases took part. The goal was to see if measuring tracer activity within the first few minutes after injection could improve diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 18F-FDOPA (a radioactive tracer used in PET scans)
What this could lead to: If successful, this could provide a more accurate way to distinguish between cancer recurrence and radiation-induced tissue damage in the brain, helping guide treatment decisions.
What could go wrong: This is a very small pilot study with only 8 participants, so results may not apply broadly. The technique is still experimental and needs much larger studies to confirm its usefulness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer metastatic malignant neoplasm in the brain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN METASTASES RADIATION NECROSIS

Contacts and locations

Locations

CHU Amiens

Amiens, Picardie, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.